Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving leading biopharmaceutical companies globally:

Express Scripts
Mallinckrodt
Johnson and Johnson
Boehringer Ingelheim
Harvard Business School
Baxter

Last Updated: December 5, 2019

DrugPatentWatch Database Preview

Suppliers and packages for generic ingredient: INSULIN DEGLUDEC; LIRAGLUTIDE

See Plans and Pricing

« Back to Dashboard

INSULIN DEGLUDEC; LIRAGLUTIDE

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package
Novo XULTOPHY 100/3.6 insulin degludec; liraglutide SOLUTION;SUBCUTANEOUS 208583 NDA Novo Nordisk 0169-2911-15 5 SYRINGE, PLASTIC in 1 CARTON (0169-2911-15) > 3 mL in 1 SYRINGE, PLASTIC
Novo XULTOPHY 100/3.6 insulin degludec; liraglutide SOLUTION;SUBCUTANEOUS 208583 NDA Novo Nordisk 0169-2911-97 1 SYRINGE, PLASTIC in 1 CARTON (0169-2911-97) > 3 mL in 1 SYRINGE, PLASTIC (0169-2911-90)
>Applicant >Tradename >Generic Name >Dosage >NDA >NDA/ANDA >Supplier >Package Code >Package

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
Baxter
Dow
Harvard Business School
Merck
AstraZeneca